Dr. Jonathan Metts, MD
Claim this profileJohns Hopkins All Children's Hospital
Studies Tumors
Studies Osteosarcoma
24 reported clinical trials
54 drugs studied
About Jonathan Metts, MD
Education:
- Obtained MD from Johns Hopkins University School of Medicine in 2015.
- Completed Residency in Pediatrics at Johns Hopkins All Children's Hospital in 2018.
- Finished Fellowship in Pediatric Cardiology at Johns Hopkins All Children's Hospital in 2021.
Experience:
- Currently serves as a Pediatric Cardiologist at Johns Hopkins All Children's Hospital.
Area of expertise
1Tumors
Stage IV
Stage I
Stage II
2Osteosarcoma
Stage IV
H3 K27M positive
Affiliated Hospitals
Clinical Trials Jonathan Metts, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Reduced Intensity BMT
for Solid Cancer
The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for patients with very high-risk solid tumors.
Recruiting1 award Phase 228 criteria
More about Jonathan Metts, MD
Clinical Trial Related2 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Jonathan Metts, MD has experience with
- Cyclophosphamide
- Vincristine
- Carboplatin
- Etoposide
- Dactinomycin
- Gemcitabine
Breakdown of trials Jonathan Metts, MD has run
Tumors
Osteosarcoma
Rhabdomyosarcoma
Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Metts, MD specialize in?
Jonathan Metts, MD focuses on Tumors and Osteosarcoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage I.
Is Jonathan Metts, MD currently recruiting for clinical trials?
Yes, Jonathan Metts, MD is currently recruiting for 9 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Metts, MD has studied deeply?
Yes, Jonathan Metts, MD has studied treatments such as Cyclophosphamide, Vincristine, Carboplatin.
What is the best way to schedule an appointment with Jonathan Metts, MD?
Apply for one of the trials that Jonathan Metts, MD is conducting.
What is the office address of Jonathan Metts, MD?
The office of Jonathan Metts, MD is located at: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida 33701 United States. This is the address for their practice at the Johns Hopkins All Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.